Virax Biolabs Group Ltd — Investor Relations & Filings
Virax Biolabs Group Ltd. is an innovative biotechnology company specializing in the detection of immune responses and the diagnosis of viral diseases. The company's core activities center on T-cell diagnostics and comprehensive immune profiling, which provide critical insights into disease mechanisms and support the development of novel therapeutic strategies. Its primary technology is the ViraxImmune™ platform, a versatile In-Vitro Diagnostic (IVD) tool applicable across various conditions. Virax Biolabs also employs advanced research tools such as ELISpot assays, a highly sensitive and specific technique for monitoring T-cell activity. Through these offerings, the company aims to accelerate the development of more effective vaccines and contribute to global health.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K | 2026-05-22 | English | |
| 6-K - Virax Biolabs Group Ltd (0001885827) (Filer) | 2026-04-14 | English | |
| 3 - Virax Biolabs Group Ltd (0001885827) (Issuer) | 2026-03-20 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English | |
| 6-K Filing | 2026-01-30 | English | |
| 424B3 | 2025-12-31 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 46858948 | 6-K | 2026-05-22 | English | ||
| 34486937 | 6-K - Virax Biolabs Group Ltd (0001885827) (Filer) | 2026-04-14 | English | ||
| 33000023 | 3 - Virax Biolabs Group Ltd (0001885827) (Issuer) | 2026-03-20 | English | ||
| 32172116 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 32172167 | 6-K Filing | 2026-01-30 | English | ||
|
2025
10 filings
| |||||
| 13532859 | 424B3 | 2025-12-31 | English | ||
| 13532862 | Regulatory Filings 2025 | 2025-12-31 | English | ||
| 13532868 | F-3 | 2025-12-18 | English | ||
| 13532873 | Regulatory Filings 2025 | 2025-12-18 | English | ||
| 13532880 | 6-K | 2025-12-04 | English | ||
| 13532887 | 6-K | 2025-12-02 | English | ||
| 13532891 | Major Shareholding Notification 2025 | 2025-10-29 | English | ||
| 13532895 | Major Shareholding Notification 2025 | 2025-10-29 | English | ||
| 13532898 | Major Shareholding Notification 2025 | 2025-10-29 | English | ||
| 13532902 | Major Shareholding Notification 2025 | 2025-10-29 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Virax Biolabs Group Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35488/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35488 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35488 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35488 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35488}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Virax Biolabs Group Ltd (id: 35488)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.